首页|微创注入肺表面活性物质技术联合咖啡因治疗新生儿呼吸窘迫综合征临床观察

微创注入肺表面活性物质技术联合咖啡因治疗新生儿呼吸窘迫综合征临床观察

扫码查看
目的 探讨微创注入肺表面活性物质(LISA)技术联合咖啡因治疗新生儿呼吸窘迫综合征(NRDS)的临床疗效。方法 选取河北省定州市人民医院2020年10月至2022年10月收治的NRDS患儿140例,按随机数字表法分为对照组和观察组,各70例。两组患儿均予咖啡因治疗,观察组患儿加用猪肺磷脂注射液(经LISA技术注入)治疗,比较两组的临床疗效。结果 观察组总有效率为91。43%,显著高于对照组的75。71%(P<0。05)。治疗后,观察组患儿的血氧分压、血氧饱和度、氧合指数均显著高于对照组(P<0。05),血二氧化碳分压显著低于对照组(P<0。05);皮质氧饱和度、脑血氧定量指数、脑氧代谢率均显著高于对照组(P<0。05);Clara细胞分泌蛋白16、转化生长因子β1、肺表面活性物质相关蛋白A水平均显著低于对照组(P<0。05)。观察组并发症发生率为7。14%,显著低于对照组的21。43%(P<0。05)。结论 微创注入LISA技术联合咖啡因治疗NRDS的临床疗效显著,可改善患儿的血气指标和脑代谢指标,抑制炎性反应,且安全性良好。
Clinical Observation of Less Invasive Surfactant Administration Technology Combined with Caffeine in the Treatment of Neonatal Respiratory Distress Syndrome
Objective To investigate the clinical efficacy of less invasive surfactant administration(LISA)technology combined with caffeine in the treatment of neonatal respiratory distress syndrome(NRDS).Methods A total of 140 children with NRDS admitted to the Dingzhou City People's Hospital from October 2020 to October 2022 were selected and divided into the control group and the observation group by the random number table method,with 70 cases in each group.The children in the two groups were treated with caffeine,and on this basis,the children in the observation group was treated with LISA technology injected with Poractant Alfa Injection.The clinical efficacy between the two groups was compared.Results The total effective rate in the observation group was 91.43%,which was significantly higher than 75.71%in the control group(P<0.05).After treatment,the levels of blood oxygen partial pressure of oxygen(PaO2),blood oxygen saturation(SpO2),and oxygenation index(OI)in the observation group were significantly higher than those in the control group(P<0.05),while the level of blood partial pressure of carbon dioxide(PaCO2)in the observation group was significantly lower than that in the control group(P<0.05).The cortical oxygen saturation(ScO2),cerebral oxygen quantification index(Cox),and cerebral oxygen metabolism rate(CMRO2)in the observation group were significantly higher than those in the control group(P<0.05).The levels of Clara cell secreted protein(CC16),transforming growth factor-β,(TGF-β 1),and pulmonary surfactant-related protein A(SP-A)in the observation group were significantly lower than those in the control group(P<0.05).The incidence of complications in the observation group was 7.14%,which was significantly lower than 21.43%in the control group(P<0.05).Conclusion LISA technology combined with caffeine injection in the treatment of NRDS has good efficacy and safety,which can improve the blood gas and brain metabolic indicators of children,and inhibit inflammatory reactions.

neonatal respiratory distress syndromeless invasive surfactant administration technologyPoractant Alfa Injectioncaffeineclinical efficacy

孙翠翠、刘金凤、吴爱华、刘玉晔、刘芳

展开 >

河北省定州市人民医院,河北保定 073000

河北省丰宁满族自治县医院,河北承德 068350

河北省廊坊市人民医院,河北廊坊 065000

新生儿呼吸窘迫综合征 微创注入肺表面活性物质技术 猪肺磷脂注射液 咖啡因 临床疗效

河北省医学科学研究重点课题计划项目

20232206

2024

中国药业
重庆市食品药品监督管理局

中国药业

CSTPCD
影响因子:1.369
ISSN:1006-4931
年,卷(期):2024.33(17)